As membrane vesicles released by adipose-derived mesenchymal stem cells (ADMSCs), ADMSCs-derived exosomes (ADMSC-Exos) contain a variety of maternally derived molecules that can broadly participate in intercellular communication and cell signaling and regulate cellular processes such as proliferation, migration, and apoptosis. Creative Biolabs focuses on and summarizes the feasibility therapeutic applications of ADMSC-Exos, hoping to help customers open up new research directions.
ADMSCs can secrete ADMSC-Exos with different molecular profiles and corresponding functions under specific conditions, and then participate in various physiological and pathological processes of the body.
Although they have bidirectional effects in some specific environments, the therapeutic advantages of ADMSC-Exos cannot be ignored. One of the major advantages of ADMSC-Exos is their ability to mimic the function of their parent cells without the risk of immune rejection or tumorigenesis. In addition, ADMSC-Exos have low immunogenicity and can bypass the blood-brain barrier, allowing them to enter target tissues and organs that are difficult to reach with traditional therapies. Furthermore, ADMSC-Exos are highly stable, making them attractive candidates for drug delivery vehicles.
The therapeutic effect of ADMSCs-Exos has been confirmed in the research of various diseases. Examples include neurological disease, cardiovascular disease, liver damage, kidney disease, and skin damage. ADMSC-Exos impedes the apoptosis of renal podocytes by restraining the Smad1/mTOR signaling pathway in renal podocytes, thereby alleviating diabetes-associated renal fibrosis. The ADMSC-Exos incorporated into the hydrogel, loaded with miR-375 through endogenous modification, can continuously and effectively upgrade the osteogenesis ability of the calvarial defect rat model in situ. Engineered ADMSC-Exos can effectively deliver the loaded miR-181-5p to damaged hepatocytes and activate autophagy-related signaling pathways to delay the process of liver fibrosis. ADMSC-Exos significantly ameliorated myocardial infarction-induced damage by activating S1P/SK1/S1PR1 signaling to upgrade macrophage M2 polarization and restrain cardiac fibroblast fibrosis. ADMSC-Exos loaded with miRNA-22 improved neuroinflammation in Alzheimer's disease mice by restraining pyroptosis and the release of inflammatory factors.
Especially in skin injury repair, a large number of studies have shown that ADMSCs-Exos can upgrade the proliferation of skin fibroblasts, and wound angiogenesis, and restrain inflammation through a variety of signaling pathways. This provides a good therapeutic strategy for both the repair of skin trauma and the improvement of skin texture.
Fig.1 Mechanisms by which ADSCs-EXOs may upgrade wound healing.1,2
In addition, ADMSCs-Exos can also be used to improve tumor chemotherapy sensitivity. ADMSCs-Exos loaded with miR-122 can restrain the proliferation and metastasis of cancer cells, and enhance the chemosensitivity of cancer cells.
With further research and development, ADMSCs-Exos may become a promising tool for improving human health and treating various diseases. Creative Biolabs has been committed to providing global customers with end-to-end Exo services. If you want to tap the feasibility of ADMSC-Exos, please contact us.
References